RA
Royce & Associates Portfolio holdings
AUM
$9.74B
1-Year Return
15.99%
This Quarter Return
-3.03%
1 Year Return
+15.99%
3 Year Return
+81.23%
5 Year Return
+192.6%
10 Year Return
+438.14%
AUM
$8.84B
AUM Growth
-$870M
(-9%)
Cap. Flow
-$349M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68
Top Buys
| 1 |
Carter's
CRI
|
$18.5M |
| 2 |
Kyndryl
KD
|
$17.6M |
| 3 |
Enovis
ENOV
|
$16.8M |
| 4 |
Macy's
M
|
$16.2M |
| 5 |
Sapiens International
SPNS
|
$15.5M |
Top Sells
| 1 |
VIVO
Meridian Bioscience Inc
VIVO
|
$47.6M |
| 2 |
Huntsman Corp
HUN
|
$19.3M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
$18.5M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
$17.4M |
| 5 |
H&R Block
HRB
|
$17M |
Sector Composition
| 1 | Industrials | 27.09% |
| 2 | Technology | 17.74% |
| 3 | Consumer Discretionary | 13.92% |
| 4 | Financials | 13.49% |
| 5 | Materials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Team
TISI
$86.4M
| $99K | ﹤0.01% |
9,330
| – | – |
|
902
Acco Brands
ACCO
$364M
| $93K | ﹤0.01% |
18,889
+6,104
| +48% | +$30.1K |
|
903
Neurogene
NGNE
$285M
| $93K | ﹤0.01% |
7,270
| – | – |
|
904
Larimar Therapeutics
LRMR
$337M
| $90K | ﹤0.01% |
28,064
| – | – |
|
|
ATTO
905
DELISTED
Atento S.A.
ATTO
| $88K | ﹤0.01% |
21,742
| – | – |
|
906
Newmark Group
NMRK
$3.28B
| $86K | ﹤0.01% |
+10,634
| New | +$86K |
|
|
WW
907
DELISTED
WW International
WW
| $85K | ﹤0.01% |
21,744
-15,945
| -42% | -$62.3K |
|
908
OppFi
OPFI
$297M
| $82K | ﹤0.01% |
+35,779
| New | +$82K |
|
909
Cineverse
CNVS
$70.8M
| $79K | ﹤0.01% |
10,000
| – | – |
|
910
Oscar Health
OSCR
$5.02B
| $79K | ﹤0.01% |
+15,889
| New | +$79K |
|
|
RNWK
911
DELISTED
RealNetworks Inc
RNWK
| $70K | ﹤0.01% |
100,171
| – | – |
|
912
Oportun Financial
OPRT
$289M
| $66K | ﹤0.01% |
+15,125
| New | +$66K |
|
|
GHL
913
DELISTED
Greenhill & Co., Inc.
GHL
| $64K | ﹤0.01% |
10,788
-8,786
| -45% | -$52.1K |
|
|
TEAD
914
Teads Holding Co. Common Stock
TEAD
$155M
| $60K | ﹤0.01% |
16,509
+6,010
| +57% | +$21.8K |
|
915
Rapid Micro Biosystems
RPID
$120M
| $58K | ﹤0.01% |
+17,900
| New | +$58K |
|
916
PLAYSTUDIOS Inc
MYPS
$122M
| $56K | ﹤0.01% |
+16,095
| New | +$56K |
|
|
LYLT
917
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $55K | ﹤0.01% |
45,197
| – | – |
|
918
Organogenesis Holdings
ORGO
$634M
| $54K | ﹤0.01% |
+16,686
| New | +$54K |
|
919
BiomX
PHGE
$13.7M
| $54K | ﹤0.01% |
15,866
-17,000
| -52% | -$57.9K |
|
920
Spire Global
SPIR
$276M
| $54K | ﹤0.01% |
6,250
| – | – |
|
|
ASPU
921
DELISTED
ASPEN GROUP, INC.
ASPU
| $54K | ﹤0.01% |
141,520
| – | – |
|
922
Rimini Street
RMNI
$416M
| $52K | ﹤0.01% |
+11,234
| New | +$52K |
|
|
CEMI
923
DELISTED
Chembio diagnostics, Inc.
CEMI
| $49K | ﹤0.01% |
135,800
| – | – |
|
924
Torrid Holdings
CURV
$176M
| $43K | ﹤0.01% |
+10,410
| New | +$43K |
|
|
AGEN
925
Agenus
AGEN
$138M
| $30K | ﹤0.01% |
746
-474
| -39% | -$19.1K |
|